Hoboken-based Innoplexus, a provider of artificial intelligence and data analytics solutions for pharmaceutical and life sciences research, announced Thursday it has opened Innoplexus Americas, a new affiliate.
The affiliate will provide pharmaceutical companies in the United States and Latin America new innovative augmented data analytics capabilities, it said.
Lawrence Ganti will serve as the CEO of Innoplexus Americas.
Ganti most recently was president of Merck KGaA’s Latin America business. Before that, he held general manager roles with Merck in Brazil and India. He was also head of commercial development for Merck’s Emerging Markets Business Unit. Before Merck, he held roles with McKinsey & Co. and various technology startups.
“Data analytics has become a core competency for pharma. It’s definitely not something you want to outsource. What brought me to Innoplexus is our approach of empowering pharma with customized ecosystems enhanced with relevant data grounded in the life sciences. Our tools and people speak the language of pharma and apply that to our AI and machine learning technologies,” Ganti said.